Vaishali Pharma Limited (NSE:VAISHALI)

Splunk Statistics

Total Valuation

Vaishali Pharma has a market cap or net worth of INR 1.54 billion. The enterprise value is 1.64 billion.

Market Cap	1.54B
Enterprise Value	1.64B

Important Dates

The last earnings date was Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Vaishali Pharma has 120.94 million shares outstanding. The number of shares has decreased by -87.95% in one year.

Current Share Class	120.94M
Shares Outstanding	120.94M
Shares Change (YoY)	-87.95%
Shares Change (QoQ)	-8.01%
Owned by Insiders (%)	44.71%
Owned by Institutions (%)	1.65%
Float	66.87M

Valuation Ratios

The trailing PE ratio is 210.42.

PE Ratio	210.42
Forward PE	n/a
PS Ratio	1.55
PB Ratio	2.37
P/TBV Ratio	2.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	200.75
EV / Sales	1.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.94

Financial Position

The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.19.

Current Ratio	2.61
Quick Ratio	1.21
Debt / Equity	0.19
Debt / EBITDA	136.87
Debt / FCF	-0.67
Interest Coverage	-0.25

Financial Efficiency

Return on equity (ROE) is 1.52% and return on invested capital (ROIC) is -0.37%.

Return on Equity (ROE)	1.52%
Return on Assets (ROA)	-0.26%
Return on Invested Capital (ROIC)	-0.37%
Return on Capital Employed (ROCE)	-0.57%
Revenue Per Employee	36.68M
Profits Per Employee	302,704
Employee Count	27
Asset Turnover	1.04
Inventory Turnover	33.02

Taxes

In the past 12 months, Vaishali Pharma has paid 4.08 million in taxes.

Income Tax	4.08M
Effective Tax Rate	33.32%

Stock Price Statistics

The stock price has decreased by -17.48% in the last 52 weeks. The beta is 0.35, so Vaishali Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-17.48%
50-Day Moving Average	12.48
200-Day Moving Average	14.77
Relative Strength Index (RSI)	54.70
Average Volume (20 Days)	571,894

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vaishali Pharma had revenue of INR 990.26 million and earned 8.17 million in profits. Earnings per share was 0.60.

Revenue	990.26M
Gross Profit	133.51M
Operating Income	-3.97M
Pretax Income	12.26M
Net Income	8.17M
EBITDA	900,000
EBIT	-3.97M
Earnings Per Share (EPS)	0.60

Balance Sheet

The company has 18.43 million in cash and 123.18 million in debt, giving a net cash position of -104.76 million or -0.87 per share.

Cash & Cash Equivalents	18.43M
Total Debt	123.18M
Net Cash	-104.76M
Net Cash Per Share	-0.87
Equity (Book Value)	649.16M
Book Value Per Share	47.94
Working Capital	644.31M

Cash Flow

In the last 12 months, operating cash flow was -180.38 million and capital expenditures -3.05 million, giving a free cash flow of -183.43 million.

Operating Cash Flow	-180.38M
Capital Expenditures	-3.05M
Free Cash Flow	-183.43M
FCF Per Share	-1.52

Margins

Gross margin is 13.48%, with operating and profit margins of -0.40% and 0.83%.

Gross Margin	13.48%
Operating Margin	-0.40%
Pretax Margin	1.24%
Profit Margin	0.83%
EBITDA Margin	0.09%
EBIT Margin	-0.40%
FCF Margin	n/a

Dividends & Yields

Vaishali Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	87.95%
Shareholder Yield	n/a
Earnings Yield	0.53%
FCF Yield	-11.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 15, 2024. It was a forward split with a ratio of 10.

Last Split Date	Oct 15, 2024
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2